NASDAQ:ABCL
AbCellera Biologics Inc.
- Stock
Last Close
3.10
26/07 20:00
Market Cap
823.35M
Beta: −0.12
Volume Today
692.61K
Avg: 1.63M
PE Ratio
−11.06
PFCF: −20.83
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | 309K - | -2.21M 815.44% | 118.92M 5,479.21% | 153.46M 29.05% | 158.52M 3.29% | -146.40M 192.35% | |
depreciation and amortization | 918K - | 1.85M 101.19% | 5.27M 185.40% | 17.25M 227.26% | 33.10M 91.90% | 30.89M 6.67% | |
deferred income tax | 2.10M - | -2.02M 196.19% | -2.11M 4.76% | 1.96M 192.72% | |||
stock based compensation | 615K - | 890.23K 44.75% | 8.40M 843.24% | 30.65M 264.96% | 49.48M 61.46% | 64.18M 29.71% | |
change in working capital | 1.91M - | 1.97M 3.25% | -116.70M 6,014.61% | 41.67M 135.71% | 29.82M 28.43% | 13.22M 55.66% | |
accounts receivables | -477K - | -1.80M 278.00% | -5.47M 203.21% | -37.39M 583.85% | -22.71M 39.24% | -45.93M 102.21% | |
inventory | -897.77K - | -150.09K 83.28% | -134.35M 89,408.64% | 40.92M 130.46% | 18.25M - | ||
accounts payables | 180K - | 150.09K 16.61% | 6.60M 4,297.88% | 1.40M 78.79% | 1.07M 23.86% | -15.10M 1,516.89% | |
other working capital | 3.11M - | 3.78M 21.59% | 16.51M 337.30% | 36.74M 122.49% | 51.47M 40.11% | 56.01M 8.81% | |
other non cash items | -188K - | 194.19K 203.29% | 4.71M 2,323.88% | 3.57M 24.16% | 8.55M 139.41% | -7.74M 190.57% | |
net cash provided by operating activities | 3.56M - | 2.69M 24.44% | 22.69M 742.33% | 244.58M 977.94% | 277.36M 13.40% | -43.88M 115.82% | |
investments in property plant and equipment | -5.31M - | -4.00M 24.69% | -14.67M 267.11% | -58.45M 298.36% | -72.66M 24.31% | -77.51M 6.67% | |
acquisitions net | -106.89M - | -41.78M 60.91% | -25.68M 38.54% | -13.69M 46.69% | |||
purchases of investments | -19.25M - | -292.24M 1,418.39% | -781.35M 167.36% | -1.07B 36.45% | |||
sales maturities of investments | 19.25M - | 27.61M 43.44% | 510.63M 1,749.58% | 910.94M 78.39% | |||
other investing activites | -1.78M - | 1.78M 200.00% | 32.62M 1,729.56% | 16.43M 49.62% | 25.31M 54.02% | ||
net cash used for investing activites | -5.31M - | -5.78M 8.91% | -119.78M 1,972.35% | -332.25M 177.38% | -352.63M 6.13% | -221.11M 37.30% | |
debt repayment | -899K - | -399.07K 55.61% | -19.94M 4,897.17% | -1.82M 90.86% | -323K 82.28% | -11.59M 3,488.24% | |
common stock issued | 2.61M - | 14.16K 99.46% | 522.84M 3,692,012.14% | 4.62M 99.12% | |||
common stock repurchased | -11.15K - | ||||||
dividends paid | -14.16K - | ||||||
other financing activites | 10.47M - | 605.05K 94.22% | 180.75M 29,774.59% | -6.68M 103.69% | -1.30M 80.46% | 21.95M 1,781.69% | |
net cash used provided by financing activities | 12.19M - | 194.83K 98.40% | 683.65M 350,804.40% | -3.89M 100.57% | -1.63M 58.11% | 10.36M 736.12% | |
effect of forex changes on cash | 283 - | -1.43M - | -9.60M 573.61% | 589K 106.14% | |||
net change in cash | 10.44M - | -2.89M 127.68% | 586.56M 20,386.71% | -92.97M 115.85% | -86.49M 6.97% | -254.04M 193.72% | |
cash at beginning of period | -283 - | 10.44M 3,690,659.36% | 7.55M 27.68% | 594.12M 7,765.96% | 501.14M 15.65% | 414.65M 17.26% | |
cash at end of period | 10.44M - | 7.55M 27.68% | 594.12M 7,766.05% | 501.14M 15.65% | 414.65M 17.26% | 160.61M 61.27% | |
operating cash flow | 3.56M - | 2.69M 24.44% | 22.69M 742.33% | 244.58M 977.94% | 277.36M 13.40% | -43.88M 115.82% | |
capital expenditure | -5.31M - | -4.00M 24.69% | -14.67M 267.11% | -58.45M 298.36% | -72.66M 24.31% | -77.51M 6.67% | |
free cash flow | -1.74M - | -1.30M 25.19% | 8.02M 715.19% | 186.13M 2,221.72% | 204.70M 9.98% | -121.38M 159.30% |
All numbers in USD (except ratios and percentages)